Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels by Arhel, Nathalie J et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Retrovirology
Open Access Short report
Wild-type and central DNA flap defective HIV-1 lentiviral vector 
genomes: intracellular visualization at ultrastructural resolution 
levels
Nathalie J Arhel†1, Sylvie Souquere-Besse†2 and Pierre Charneau*1
Address: 1Groupe de Virologie Moléculaire et Vectorologie, Institut Pasteur, 25–28 rue du Dr. Roux, 75724 Paris, France and 2Institut André Lwoff, 
CNRS-FRE2937, 7 rue Guy Moquet-BP8, 94800 Villejuif, France
Email: Nathalie J Arhel - arhel@pasteur.fr; Sylvie Souquere-Besse - souquere@vjf.cnrs.fr; Pierre Charneau* - charneau@pasteur.fr
* Corresponding author    †Equal contributors
Abstract
HIV-1 and other lentiviruses have the unique ability among retroviruses to efficiently replicate in
non-dividing cells as a result of the active nuclear import of their DNA genome across an
interphasic nuclear membrane. Previous work has shown that a three-stranded DNA structure
synthesized during HIV-1 reverse transcription, called the central DNA flap, acts as a cis-
determinant of HIV-1 genome nuclear import. Concordantly, DNA Flap re-insertion in lentiviral-
derived gene therapy vectors stimulates gene transfer efficiencies and complements the level of
nuclear import to wild-type levels quantitatively indistinguishable from wild-type virus in all cell
types and tissues examined so far. In order to define the precise nature of the replicative defect of
DNA flap mutant viruses, we carried out in situ DNA hybridization experiments with electron
microscopy to determine the subcellular localization of DNA flap mutant and wild-type HIV-1
genomes. We found that Flap defective DNA genomes accumulate at the cytoplasmic face of the
nuclear membrane with no overlap across the nuclear membrane, whereas wild-type genomes
localize throughout the nuclear compartment. These data provide an unequivocal confirmation of
the role of the DNA flap in HIV-1 nuclear import and further establish that the DNA flap controls
a step that immediately precedes translocation through the nuclear pore. Further, the widespread
distribution of wild-type genomes within the open chromatin confirms the recent genome-wide
mapping of HIV-1 cDNA integration sites and points to an as-yet poorly understood step of
intranuclear transport of HIV-1 pre-integration complexes.
Findings
HIV-1 and other lentiviruses have evolved a more com-
plex reverse transcription strategy than oncoviruses
whereby the presence of two additional cis-acting
sequences within the lentiviral genome, the central poly-
purine tract (cPPT) and the central termination sequence
(CTS), leads to the formation of a three-stranded DNA
structure called the central DNA Flap [1-3]. Mutations
within the cPPT lead to a linear genome lacking the cen-
tral DNA Flap and severely impair viral replication [2,4].
While wild-type viral DNA is almost entirely imported
into the nucleus where it either integrates or circularizes,
DNA Flap defective viral DNA accumulates as uninte-
grated linear DNA as a consequence of a lack of access to
the nuclear compartment, indicating a defect in nuclear
import [4].
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Consistently with the cis-acting role of the central DNA
Flap in HIV-1 genome nuclear import, its reinsertion in
HIV-1 derived gene transfer vectors can complement the
level of nuclear import from a strong defect to wild-type
nuclear import levels, quantitatively indistinguishable
from wild-type virus [4]. As a result, DNA Flap containing
lentiviral vectors closely mimic the early steps of wild-type
virus infection. Reinsertion of the DNA Flap in HIV-1 vec-
tors stimulated gene transfer efficiencies both in vivo and
ex vivo in all tissue- and cell-types examined [5-14], thus
making the DNA Flap an essential and widely-used com-
ponent of lentiviral gene therapy vectors.
In an effort to elucidate the mechanistic implication of the
central DNA Flap in HIV-1 nuclear import, we sought to
precisely characterize the nature of the nuclear import
defect of DNA Flap mutant viruses. We previously found,
using subcellular fractionation experiments together with
localization of viral DNA by fluorescence in situ hybridi-
zation (FISH) that central DNA Flap defective molecules
accumulate at close proximity to the nuclear compart-
ment indicating a late defect in nuclear import following
a normal and rapid routing process of viral complexes
from the plasma membrane to the nuclear membrane [4].
However, the precise nature of the nuclear import replica-
tive defect, such as translocation through the nuclear pore
or any step that immediately precedes or follows translo-
cation, was not known.
We therefore sought to define with ultrastructural resolu-
tion the subcellular compartment of accumulation of
Flap+ versus Flap- HIV-1 genomes. We carried out in situ
DNA hybridization with electron microscopy on MT4
cells transduced with HIV-1 derived vectors, including or
not the central DNA Flap. MT4 cells are HTLV-1 trans-
formed human CD4+ T lymphocytes, maintained in
RPMI 1640 medium supplemented with 10% FCS. MT4
cells are highly permissive to transduction, while vectors
benefit from higher titers compared to viruses, thus opti-
mizing the detection of vector DNA within cell sections.
In addition, the use of HIV-1 replication defective vectors
enabled us to limit our observations to one-round trans-
duction events. The HIV-1 vector HR, derived from
HR'CMVLacZ [15], does not contain the cis-acting
sequences required for formation of the central DNA Flap.
The HIV-1 vector TRIP is identical to HR but with the DNA
Flap sequences reinserted within the vector sequence.
HIV-1 vectors were produced as previously described [15].
Carry-over DNA in the vector supernatants was eliminated
by treating the vector stocks with DNase I (1 µg/ml in the
presence of 1 µM MgCl2) for 15 min at 37°C.
MT4 lymphocytes were transduced with the TRIP Flap+ or
HR Flap- vector, with a multiplicity of infection of 100, as
determined from the number of copies of provirus per cell
by quantitative PCR (a high MOI is required for viral DNA
detection by in situ DNA hybridization with electron
microscopy). At 48 hr post-transduction, a time point
when most incoming complexes, in the context of a
highly asynchronous infection, have completed the entire
early steps phase and have reached their final state [4],
transduced and non-transduced cells were fixed in 4% for-
maldehyde (Merck) in 0.1 M Sörensen's phosphate buffer,
pH 7.3, at 4°C for 1 hr. These were then dehydrated in
methanol and embedded at low temperature in Lowicryl
K4M (Polysciences Europe, Germany). Polymerization
was carried out under long wavelengh UV light at -30°C.
Ultrathin sections were collected onto carbon-Formvar-
coated gold grids (200 mesh). In situ DNA hybridization
was carried out as previously described [16] using a bioti-
nylated double-stranded vector specific DNA probe [4]
(please refer to Additional file 1 for a detailed protocol for
HIV-1 DNA genome detection by in situ DNA hybridiza-
tion and electron microscopy). Prior to hybridization the
grids underwent a series of successive enzymatic and
denaturation treatments (Table 1): bacterial protease type
VI (Sigma, St Louis, MO/USA) to render the DNA accessi-
ble to the probe, RNase A (BDH Biochemical Ltd, UK) to
Table 1: Sequential experimental steps for in situ hybridization
Step Material Concentration Buffer Duration Temperature
Fixation Paraformaldehyde 4% Sörensen 1 hr 4°C
Lowicryl embedding 5 days -30°C
Sectioning (gold grids)
Enzymatic digestion Proteasea 0.2 mg/ml Distilled water 15 min 37°C
RNase Ab 1 mg/ml Tris HCl, 10 mM, pH 7.3 1 hr 37°C
Denaturation of grid target DNA NaOH 0.5 N Distilled water 4 min RTd
Denaturation of hybridization solution 4 min 95°C
Hybridization o/nc 37°C
Detection of hybrids Anti-biotin 10 nm gold conjugate 1:25 PBS 30 min RTd
a The aim of this step is to eliminate proteins within the section which could otherwise interfere with binding of the probe to the target DNA. b The 
aim of this step is to eliminate all RNA molecules including viral RNA to prevent their concomittant detection with viral DNA. c Overnight. d Room 
temperatureRetrovirology 2006, 3:38 http://www.retrovirology.com/content/3/1/38
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eliminate RNA sequences including those that are homol-
ogous to the probe, NaOH treatment to denature the DNA
present in the sections, and heat treatment to denature the
double-stranded DNA probe. Vector DNA-probe hybrids
were detected within 90 nm thick sections by direct
immunogold labeling using anti-biotin conjugated 10 nm
colloidal gold particles (British Biocell International)
diluted 1/25 in PBS, for 30 min at room temperature.
Grids were stained with uranyl acetate prior to observa-
tion. The specificity of the hybridization signals was con-
firmed by negative results following additional DNase I
treatment of sections prior to hybridization (1 mg/ml,
Worthington Biochem. Corp.) at 37°C for 1 hr (data not
shown), and in situ DNA hybridization of non-transduced
cells (Figure 3A). Samples were observed with a Philips
400 electron microscope at 80 kV.
The images that we show were taken from 4 independent
cell population infections and inclusions, and 25 hybrid-
ization experiments. In every experiment, each electron
transmission grid contained 5 sample slices, each of
which contained 10–20 cell sections. Therefore, approxi-
mately 1,250 to 2,500 cells were observed for the purpose
of this study. In the context of HIV infection, detection by
in situ DNA hybridization and immuno-gold staining is a
rare event, even when using a permissive target cell such
as MT4 and high multiplicity of infection. As a result,
about 5–10% of cells observed actually contained DNA
hybridization signal. Importantly, all cell areas containing
DNA hybridization signal were systematically photo-
graphed (about 150–200 photos). Observations were car-
ried out in single-blind conditions, and images shown are
highly representative of all data obtained.
We found that wild-type vector DNA including the DNA
Flap accumulates predominantly within the nucleus of
transduced cells 48 hr post-transduction, and more specif-
ically within open regions of the chromatin (Figure 1).
The detection of vector DNA hybridization signals does
not discriminate between integrated proviruses and DNA
circles, therefore intranuclear signals do not all necessarily
correspond to actively transcribed genomes. At 48 hr post-
transduction, previous DNA profile analyses showed that
~55% of nuclear localized genomes are integrated provi-
ruses, the rest being one-long terminal repeat (LTR) DNA
circles and few 2-LTR circles [4].
DNA Flap defective viral genomes, on the other hand,
accumulate predominantly on the cytoplasmic face of the
nuclear membrane (Figure 2), confirming a nuclear
import defect of Flap defective pre-integration complexes
that does not implicate the routing process from the
plasma membrane to the nucleus. As previously shown,
there is no degradation of this cytoplasmic linear uninte-
grated viral DNA between 12 and 48 hr post-transduction
[4]. Importantly here, DNA hybridization signals remain
on the cytoplasmic side of the nuclear membrane, with no
overlap across the nuclear membrane, revealing that Flap
defective DNA molecules have not initiated translocation
through the nuclear pore. Non-transduced control sam-
ples exhibited negligible background signal (Figure 3A).
Precise quantification of DNA hybridization signals 48 hr
post-transduction on randomly selected micrographs
(Figure 3B) revealed a strong accumulation of nuclear ver-
sus cytoplasmic vector DNA in the case of DNA Flap+ vec-
tor with an average nuclear/cytoplasmic ratio of 3.9 ± 0.9,
which means that 77.3 ± 3.6% of total vector DNA was
detected within the nuclear compartment. Conversely,
there was a strong accumulation of cytoplasmic versus
nuclear vector DNA in the case of DNA Flap- vector with
an average nuclear/cytoplasmic ratio of 0.2 ± 0.04, which
corresponds to 86.4 ± 2.8% of total vector DNA being
detected in the cytoplasm. Results are highly statistically
significant (p < 0.0001, Mann-Whitney test) and consist-
ent with published intracellular vector DNA profiles
assessed by quantitative Southern blotting [4].
This is, to our knowledge, the first report of the intracellu-
lar visualization of HIV-1 DNA genomes by in situ DNA
hybridization with electron microscopy. The data we
obtained reveal that lack of the central DNA Flap results in
perinuclear accumulation of viral genomes that do not
overlap across the nuclear membrane, indicating a defect
preceding translocation of pre-integration complexes
through the nuclear pore. Of note and as we previously
reported [4], absence of the central DNA Flap does not
entirely preclude HIV-1 genome nuclear import. The ~10–
20% of Flap- genomes that are imported into the nucleus
points to a Flap-independent nuclear import mechanism
that likely accounts for transduction levels obtained with
Flap- vectors, a current area of investigation in our labora-
tory.
The search for the viral determinants responsible for the
active nuclear import of the HIV-1 DNA genome has con-
stituted an active but controversial field of investigation.
Based on the search of a sequence that obeys the consen-
sus for nuclear localization, three HIV-1 proteins, MA, Vpr
and IN, have been proposed to contribute in a redundant
manner to the karyophilic properties of the HIV-1 pre-
integration complex [[17-19], among others]. However,
the actual participation of these proteins in HIV-1 genome
nuclear import is a matter of strong debate [[20-23],
among others]. The implication of the central DNA Flap
in HIV-1 nuclear import has also been questioned in two
reports [24,25] that suggested the central DNA Flap, while
important in the context of HIV-1 derived vectors, not to
be essential for HIV-1 replication. However, detailed anal-
yses of virus infectivity revealed that all cPPT mutant
viruses exhibit reduced infectivity and defective nuclearRetrovirology 2006, 3:38 http://www.retrovirology.com/content/3/1/38
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Ultrastructural subcellular localization of HIV-1 derived vector genomes including the central DNA Flap (Flap +) Figure 1
Ultrastructural subcellular localization of HIV-1 derived vector genomes including the central DNA Flap (Flap 
+). Electron micrographs showing MT4 cells 48 hr following transduction with the TRIP Flap+ vector. Vector DNA genomes 
including the DNA Flap are found predominantly within the nucleus. N = nucleus; ne = nuclear envelope; nu = nucleolus; C = 
cytoplasm. Images show one low and four high magnification micrographs. The first high magnification micrograph is an enlarge-
ment from the low magnification image. The other three are taken from other independent experiments. All are highly repre-
sentative of the data obtained. Arrows point to clusters of immunogold labeled vector DNA.Retrovirology 2006, 3:38 http://www.retrovirology.com/content/3/1/38
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Ultrastructural subcellular localization of HIV-1 derived vector genomes without the central DNA Flap (Flap -) Figure 2
Ultrastructural subcellular localization of HIV-1 derived vector genomes without the central DNA Flap (Flap -
). MT4 cells 48 hr post-transduction with the HR Flap- vector. DNA Flap defective vector genomes localize on the cytoplasmic 
side of the nuclear membrane. N = nucleus; ne = nuclear envelope; C = cytoplasm. Images show one low and four high magni-
fication micrographs. The first high magnification micrograph is an enlargement from the low magnification image. The other 
three are taken from other independent experiments. All are highly representative of the data obtained. Arrows point to clus-
ters of immunogold labeled vector DNA.Retrovirology 2006, 3:38 http://www.retrovirology.com/content/3/1/38
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import irrespective of the viral genetic background or tar-
get cells (manuscript submitted). Here, the ultrastrucutral
localization of Flap defective molecules confirms that the
central DNA Flap is a cis-acting DNA motif that is impli-
cated in HIV-1 nuclear import. The inhibition of nuclear
import in the absence of this motif, although not abso-
lute, points to a mechanistic implication of the DNA Flap
in a step immediately prior to translocation of the viral
genome through the nuclear pore. Other viral factors, and
conceivably many cellular factors, are also expected to
contribute to the active nuclear import of HIV-1.
In the case of Flap+ vector genomes, hybridization signals
were detected predominantly within the open regions of
the chromatin, confirming previous work showing prefer-
ential integration of HIV-1 within actively transcribed
genes [26-28]. Moreover, signals are visualized through-
out the nuclear compartment, without particular prefer-
ence for areas close to the nuclear membrane, indicating
probable intranuclear transport events of HIV-1 DNA
genomes after translocation through the nuclear mem-
brane and until the integration sites are reached. This con-
curs with the recent HIV-1 integration site mapping
showing integration throughout the genome [26]. The
nature and mechanisms of this intranuclear transport
remain entirely to be characterized.
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Quantification of intracellular vector genome detection Figure 3
Quantification of intracellular vector genome detection. (A) Electron micrograph of control non-transduced cells 
showing minimal background signal. (B) DNA hybridization signals from 4 independent cell population infections were counted 
and represented as total nuclear over cytoplasmic signal ratio. All cell areas containing DNA hybridization signal were system-
atically photographed (about 150–200 photos) and signal was carefully quantified, each time with equal surface of nuclear and 
cytoplasmic compartments. The p value (Mann-Whitney test) shows the results are highly statistically relevant.Publish with BioMed Central    and   every 
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